Drug Shortage Report for TEVA-MYCOPHENOLATE

Last updated on 2020-07-03 History
Report ID 107949
Drug Identification Number 02364883
Brand name TEVA-MYCOPHENOLATE
Common or Proper name MYCOPHENOLATE 250MG CAPS
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) MYCOPHENOLATE MOFETIL
Strength(s) 250MG
Dosage form(s) CAPSULE
Route of administration ORAL
Packaging size U/D 100's
ATC code L04AA
ATC description IMMUNOSUPPRESSANTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-03-18
Estimated end date 2020-06-30
Actual end date 2020-06-30
Shortage status Resolved
Updated date 2020-07-03
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v21 2020-07-03 French Compare
v20 2020-07-03 English Compare
v19 2020-07-03 English Compare
v18 2020-06-16 French Compare
v17 2020-06-16 English Compare
v16 2020-05-21 French Compare
v15 2020-05-21 English Compare
v14 2020-05-14 French Compare
v13 2020-05-14 English Compare
v12 2020-05-08 French Compare
v11 2020-05-08 English Compare
v10 2020-05-08 French Compare
v9 2020-05-08 English Compare
v8 2020-05-01 French Compare
v7 2020-05-01 English Compare
v6 2020-04-09 French Compare
v5 2020-04-09 English Compare
v4 2020-03-19 French Compare
v3 2020-03-19 English Compare
v2 2020-03-06 French Compare

Showing 1 to 20 of 21